Goldstream Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-42,225	Closed	-$2.47M	–	28
2021 Q4	$2.47M	Buy	+42,225	New	+$2.47M	0.61%	18